BioGaia Prodentis lozenges are a daily probiotic supplement for healthy gums and fresh breath. Proper oral hygiene goes beyond brushing and flossing – it’s important to your general health and well-being. Each minty-fresh lozenge contains two high-quality, patented bacterial strains of …

Oct 11, 2018 · Isomalt, xylitol, L. reuteri Prodentis Blend (L. reuteri ATCC PTA 5289 and L. reuteri DSM 17938), natural peppermint flavor, natural menthol flavor, calcium stearate. 1 lozenge per day. Let the lozenge melt in your mouth, preferably after brushing your teeth. Use regularly for good oral health.*

As compared to S/RSD with placebo, a 28-day course of adjunctive probiotic L. reuteri lozenges improved CAL change at molar sites with ≥ 5 mm deep pockets and conferred a higher probability of shallow residual pocket depth.

Limosilactobacillus reuteri (L. reuteri) is a type of probiotic ("good" bacteria) normally found in the digestive tract. It produces lactic acid in the gut.

Objective: The aim of this 12-month mono-centre double-blind randomized placebo-controlled clinical study was to evaluate the efficacy of Lactobacillus reuteri-containing lozenges during the supportive therapy of generalized periodontitis stage III and IV, grade C (GPIII-IVC) patients.

This systematic review aimed to understand the efficacy of the Lactobacillus reuteri (L. reuteri) as an adjuvant in nonsurgical periodontal treatment. It included 9 articles that demonstrated the influence of that specific probiotic in patients who underwent nonsurgical treatment …

Lozenges with L. reuteri Prodentis® may be a useful supplement in moderately patients with Chronic Periodontitis. Low MMP-8 and high TIMP-1 levels may indicate the role of the lozenges in reduction of inflammation-associated markers up to day. Duration : Probiotic supplementation for 21 days, initiated after periodontal therapy.

L. reuteri-containing lozenges may be a useful adjuvant agent to slow re-colonization and improve clinical outcomes of chronic periodontitis. Further studies are required to clarify the optimal dose of the lozenges.

Jun 8, 2020 · To evaluate effects of probiotic Lactobacillus reuteri ( L. reuteri) lozenges as an S/RSD adjunct on site-level changes at molars with deep pockets. 447 molar sites with pockets ≥ 5 mm from a previous randomized clinical trial of adjunctive L. …

The aim of this 12-month mono-centre double-blind randomized placebo-controlled clinical study was to evaluate the efficacy of Lactobacillus reuteri-containing lozenges during the supportive therapy of generalized periodontitis stage III and IV, grade C (GPIII-IVC) patients.